Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +37.44%
#3 Glidr Glidr +35.94%
#4 Humanity Humanity +25.03%
#5 Tutorial Tutorial +21.66%
#6 Enso Enso +21.56%
#7 Codatta Codatta +19.97%
#8 Walrus Walrus +19.47%
#9 BOOK OF MEME BOOK OF MEME +18.59%
#10 Ribbita by Virtuals Ribbita by Virtuals +13.44%
Coin of the day
EXOD EXOD
設定
言語
日本
通貨
USD
テーマ
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited

ASLN
株式のランク #37031
ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the... ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the clinical stage, primarily focused on immunology, and dedicated to creating innovative treatments that profoundly enhance patients' lives. Its advanced therapeutic pipeline features ASLAN004, a monoclonal antibody currently being evaluated for atopic dermatitis and a range of other immunological disorders. Also under development is ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase, intended to treat autoimmune conditions. The company is involved in a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd., aimed at pioneering immuno-oncology therapeutics that target the AhR pathway. Furthermore, ASLAN maintains partnerships with various entities, including Almirall, Array BioPharma, and CSL Limited. Established in 2010, the company's headquarters are located in Singapore.
株価
$0.6
最終同期: 2024-08-14
時価総額
$2.09M
変化（1日）
0.00%
変化（1年）
0.00%
国
SG
取引 ASLAN Pharmaceuticals Limited (ASLN)

カテゴリー

Healthcare
ASLAN Pharmaceuticals Limited（ASLN）の収益
Mar 2024 時点の収益 TTM: $12.00M
ASLAN Pharmaceuticals Limited の最新の財務報告によると、現在の収益 (TTM) は $12.00M です。2022 年には 0.00 の収益があり、これは 2021 年の 0.00 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
ASLAN Pharmaceuticals Limited の収益履歴（2014 ～ 2026）
各年末の収益
年 収益 変化
2026 (TTM) $12.00M 0.00%
2023 $12.00M 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
2020 0.00 -100.00%
2019 $3.00M 0.00%
2018 0.00 0.00%
2017 0.00 -100.00%
2016 $11.49M 0.00%
2015 0.00 0.00%
2014 0.00 0.00%
同業他社の収益
企業 収益 収益の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 105,102.50%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 50,077.39%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B 84,156.56%
BE